Oculus Biologics
Oculus Biologics is a regenerative medicine company focused on assisting physicians in providing optimal patient care through advanced treatment solutions. Their core technology, LYOTEK, is a proprietary processing technique for lyophilized amnion, offering benefits such as preserved matrix, optimal ECM preservation, and convenient ambient temperature storage. Their primary product, XcellerEYES, is a lyophilized ophthalmic membrane designed for clinical and surgical vision applications, performing similarly to cryopreserved tissue but with enhanced ease of use and storage. The company aims to establish new industry standards in regenerative medicine through continuous research and development.
Oculus Biologics
Oculus Biologics is a regenerative medicine company focused on assisting physicians in providing optimal patient care through advanced treatment solutions. Their core technology, LYOTEK, is a proprietary processing technique for lyophilized amnion, offering benefits such as preserved matrix, optimal ECM preservation, and convenient ambient temperature storage. Their primary product, XcellerEYES, is a lyophilized ophthalmic membrane designed for clinical and surgical vision applications, performing similarly to cryopreserved tissue but with enhanced ease of use and storage. The company aims to establish new industry standards in regenerative medicine through continuous research and development.